ARCA Biopharma to Divest Technology and IP in Oruka Merger
ARCA Biopharma Inc. (Nasdaq: ABIO), a Westminster company known for its focus on genetically targeted…
Subscriber Membership Required
You must be a Subscriber member to access this content.
Already a member? Log in here
